Fibrocell Science Inc. (FCSC)

2.07 0 (0%)

IEX Real-Time Price

November 16, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 2.07

Price Open 2.04

Volume: 103,672

Avg Volume: 150,322

Market Cap: 19.28M

P/E Ratio -0.45

52 Wk Range 1.75-9



FCSC Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
5.66M
971,493
3.92
17.18%

2018-09-28
5.66M
984,107
3.39
17.40%

2018-09-14
5.66M
954,072
5.48
16.87%

2018-08-31
5.66M
940,452
10.79
16.63%




FCSC Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-08-09
Q2 2018
BTO
-0.42 (1)
-0.49
-0.07

2018-05-10
Q1 2018
BTO
-0.85 (1)
-0.49
-0.07

2018-05-09
Q1 2018
N/A
-0.22 (2)
-0.49
-0.07

2018-03-19
Q4 2017
BTO
-0.23 (2)
-0.49
-0.07

News

Fibrocell Science, Inc. (FCSC) CEO John Maslowski on Q2 2018 Results - Earnings Call Transcript (2018-11-13 12:24 SeekingAlpha)

Fibrocell Science, Inc. (NASDAQ:FCSC) Q3 2018 Earnings Conference Call November 13, 2018 8:30 AM ET Executives Karen Casey - Investor and Media Relations John Maslowski - President and Chief Executive Officer Sean Buckley - Vice President of Business Administration, Corporate …

 

Fibrocell Science, Inc. 2018 Q3 - Results - Earnings Call Slides (2018-11-13 10:01 SeekingAlpha)

The following slide deck was published by Fibrocell Science, Inc. in conjunction with their 2018 Q3 earnings Read more …

 


Statistics

Shares Outstanding: 9.31M

Top 15 Institution Percent: 102.50

Price To Sales: N/A

Price To Book: 2.06

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -21.65

Return On Equity: -128.60

Profit Margin: N/A

Price History

Beta: 0.85

50-day Moving Avg: 2.11

200-day Moving Avg: 2.57

YTD Change: -40.00

5-day Change: 6.70

1-month Change: 5.08

3-month Change: 1.97

6-month Change: -30.82

1-year Change: -74.13

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Fibrocell Science Inc.

Exchange: NASDAQ Capital Market

Industry: Drug Manufacturers

Sector: Healthcare

Website: http://www.fibrocell.com

Fibrocell Science Inc is a commercial-stage, autologous cellular therapeutic company that develops products for aesthetic, medical and scientific applications.